Helen F. Graham Cancer Center — Newark, Delaware

Helen F. Graham Cancer Center is a clinical research site located in Newark, Delaware, United States 19713.

Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.

Helen F. Graham Cancer Center has participated in 21 clinical trials with 1 currently active.

Therapeutic areas: Carcinoma, Squamous Cell of Head and Neck, Early Breast Cancer, Breast Cancer.

Sponsors: Celgene, ETOP IBCSG Partners Foundation, Alliance for Clinical Trials in Oncology.

Sponsor Feasibility Report

Trust Score: 82/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Helen F. Graham Cancer Center?

Helen F. Graham Cancer Center has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Helen F. Graham Cancer Center conducted?

Helen F. Graham Cancer Center has 21 clinical trials on record, with 1 currently active. Their work covers Carcinoma, Squamous Cell of Head and Neck, Early Breast Cancer, Breast Cancer.

Is Helen F. Graham Cancer Center accredited by Crixeo Health?

Helen F. Graham Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Helen F. Graham Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.